We can buy this stock at 0,30$, GlycoMimetics Inc, with address at 9708 MEDICAL CENTER DRIVE, ROCKVILLE, Maryland, 20850, United States, is a publicly traded company and its visible heads at the moment are Armand Girard (Chief Business Officer & Senior Vice President), Brian M. Hahn (Chief Financial Officer & Senior Vice President), Eric Feldman (Chief Medical Officer & Senior Vice President), Harout Semerjian (President, Chief Executive Officer & Director), Henry Flanner (Vice President-Technical Operations), John L. Magnani (Chief Scientific Officer & Senior VP-Research). Focused on Biotechnology: Pharmaceutical Preparations was created long ago in United States.
The closing price of the stock yesterday was desconocido$.
With an intraday difference of 0,30$ moving between 0,28$ and 0,31$, it is a notable difference that allows quick purchases and sales.
Their latest annual data shows an income of desconocido.
The last registered opening is of desconocido.
One of the most interesting values to assess whether the price of a share is low or high is the minimum and maximum price of the last 52 weeks, in this case it has varied between 0,00$ and 0,00$.
Earnings per share, or EPS, is a value also used to assess whether a company has obtained sufficient net profits for the number of shares it has for sale. In this case it is [BPA], but it must be taken into account that there may have been increases or decreases in capital that influence the value.
Buscar
